Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Ministero della Salute (J59H06000160001)
- License Information
-
More Information
Article History
Received: 28 October 2022
Accepted: 20 July 2023
First Online: 29 July 2023
Declarations
:
: The study was exempt from patients informed consent (according to General Authorization for the Processing of Personal Data for Scientific Research Purposes Issued by the Italian Privacy Authority on August 10, 2018; ExternalRef removed), therefore the need for ethics approval was not necessary according to National regulations.
: Not applicable.
: GC received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry for University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as member of Advisory Board from Roche. No other potential conflicts of interest relevant to this article were disclosed. All the other authors declare that they have no competing interests.
